Literature DB >> 31208312

Design and Biological Evaluation of Novel Imidazolyl Flavonoids as Potent and Selective Protein Tyrosine Phosphatase Inhibitors.

Rong Y Han1, Yu Ge1, Ling Zhang1, Qing M Wang1.   

Abstract

BACKGROUND: Protein tyrosine phosphatases 1B are considered to be a desirable validated target for therapeutic development of type II diabetes and obesity.
METHODS: A new series of imidazolyl flavonoids as potential protein tyrosine phosphatase inhibitors were synthesized and evaluated.
RESULTS: Bioactive results indicated that some synthesized compounds exhibited potent protein phosphatase 1B (PTP1B) inhibitory activities at the micromolar range. Especially, compound 8b showed the best inhibitory activity (IC50=1.0 µM) with 15-fold selectivity for PTP1B over the closely related T-cell protein tyrosine phosphatase (TCPTP). Cell viability assays indicated that 8b is cell permeable with lower cytotoxicity. Molecular modeling and dynamics studies revealed the reason for selectivity of PTP1B over TCPTP. Quantum chemical studies were carried out on these compounds to understand the structural features essential for activity.
CONCLUSION: Compound 8b should be a potential selective PTP1B inhibitor. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Flavonoid; cell viability; imidazole; molecular modeling; protein tyrosine phosphatase; selectivity.

Mesh:

Substances:

Year:  2020        PMID: 31208312     DOI: 10.2174/1573406415666190430125547

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  1 in total

1.  Docosahexaenoic Acid Inhibits PTP1B Phosphatase and the Viability of MCF-7 Breast Cancer Cells.

Authors:  Alicja Kuban-Jankowska; Magdalena Gorska-Ponikowska; Kamlesh Kumar Sahu; Tomasz Kostrzewa; Michal Wozniak; Jack Tuszynski
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.